David Allen Barbie, Mingchao Xie, Maria Broggi, Ying Cheng, David R. Spigel, Byoung Chul Cho, Jian Fang, Yuanbin Chen, Yoshitaka Zenke, Ki Hyeong Lee, Qiming Wang, Alejandro Navarro, Eva Lotte Buchmeier, Mustafa Özgüroğlu, Christine L. Hann, Jocelyn Chen, Wei-Chu Victoria Lai, Yashaswi Shrestha, Suresh Senan. "Clinical and molecular characteristics of early progressors (EPs) and long-term progression-free survivors (LTPs) from the phase 3 ADRIATIC trial of consolidation durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8014